Cargando…
Identification of early and intermediate biomarkers for ARDS mortality by multi-omic approaches
The lack of successful clinical trials in acute respiratory distress syndrome (ARDS) has highlighted the unmet need for biomarkers predicting ARDS mortality and for novel therapeutics to reduce ARDS mortality. We utilized a systems biology multi-“omics” approach to identify predictive biomarkers for...
Autores principales: | Liao, S. Y., Casanova, N. G., Bime, C., Camp, S. M., Lynn, H., Garcia, Joe G. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460799/ https://www.ncbi.nlm.nih.gov/pubmed/34556700 http://dx.doi.org/10.1038/s41598-021-98053-1 |
Ejemplares similares
-
The acute respiratory distress syndrome biomarker pipeline: crippling gaps between discovery and clinical utility
por: Bime, Christian, et al.
Publicado: (2020) -
Linkage of NAMPT promoter variants to eNAMPT secretion, plasma eNAMPT levels, and ARDS severity
por: Lynn, Heather, et al.
Publicado: (2023) -
Development of a biomarker mortality risk model in acute respiratory distress syndrome
por: Bime, Christian, et al.
Publicado: (2019) -
Targeting SELPLG/P‐selectin glycoprotein ligand 1 in preclinical ARDS: Genetic and epigenetic regulation of the SELPLG promoter
por: Sun, Xiaoguang, et al.
Publicado: (2023) -
Multi-omic characterization of pediatric ARDS via nasal brushings
por: Williams, James G., et al.
Publicado: (2022)